Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
出版年份 2015 全文链接
标题
Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
作者
关键词
Epidermal growth factor receptor (EGFR), Targeted therapies, Resistance to treatment, Glioblastoma, Systems biology
出版物
Cell Communication and Signaling
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-03-31
DOI
10.1186/s12964-015-0098-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Busting robustness: using cancer’s greatest strength to our advantage
- (2015) Jason R Westin Future Oncology
- Change or die: Targeting adaptive signaling to kinase inhibition in cancer cells
- (2014) Vito W. Rebecca et al. BIOCHEMICAL PHARMACOLOGY
- Open questions: The disrupted circuitry of the cancer cell
- (2014) H Steven Wiley BMC BIOLOGY
- The mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma
- (2014) Mitsutoshi Nakada et al. Brain Tumor Pathology
- EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis
- (2014) Haizhong Feng et al. JOURNAL OF CLINICAL INVESTIGATION
- Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies
- (2014) P. Roth et al. NEURO-ONCOLOGY
- A Unique Four-Hub Protein Cluster Associates to Glioblastoma Progression
- (2014) Pasquale Simeone et al. PLoS One
- Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNF in glioblastoma
- (2014) Y. Kusne et al. Science Signaling
- Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases
- (2014) X. Wan et al. Science Translational Medicine
- Receptor Tyrosine Kinases: Legacy of the First Two Decades
- (2014) J. Schlessinger Cold Spring Harbor Perspectives in Biology
- The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
- (2014) M. A. Lemmon et al. Cold Spring Harbor Perspectives in Biology
- Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment
- (2014) Mattia Lauriola et al. Nature Communications
- Robustness and Evolvability of the Human Signaling Network
- (2014) Junil Kim et al. PLoS Computational Biology
- EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
- (2013) Qi-Wen Fan et al. CANCER CELL
- Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas
- (2013) Kai-liang Zhang et al. CANCER LETTERS
- Encoding and Decoding Cellular Information through Signaling Dynamics
- (2013) Jeremy E. Purvis et al. CELL
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma
- (2013) Qinglei Gao et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
- (2013) Mikael Johansson et al. NEURO-ONCOLOGY
- An EGFR wild type–EGFRvIII–HB-EGF feed-forward loop regulates the activation of EGFRvIII
- (2013) L Li et al. ONCOGENE
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
- (2013) M. J. Niederst et al. Science Signaling
- Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression
- (2013) Shannon Patricia Fortin Ensign et al. Frontiers in Oncology
- Mechanisms of Glioma-Associated Neovascularization
- (2012) Matthew E. Hardee et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting oncogenic Ras signaling in hematologic malignancies
- (2012) A. F. Ward et al. BLOOD
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
- (2012) Woody Han et al. CANCER LETTERS
- The small GTPase RhoG mediates glioblastoma cell invasion
- (2012) Aneta Kwiatkowska et al. Molecular Cancer
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth
- (2012) Guillem Ramis et al. PLoS One
- Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240
- (2012) T. R. Fenton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme
- (2012) S.-S. Suh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis
- (2012) H. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Compensatory Pathways in Oncogenic Kinase Signaling and Resistance to Targeted Therapies: Six Degrees of Separation: Figure 1.
- (2012) Livio Trusolino et al. Cancer Discovery
- Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
- (2012) Igor Vivanco et al. Cancer Discovery
- EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis
- (2011) Xinyu Cao et al. Molecular Cancer
- Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib--A Phase II Trial
- (2011) M. E. Hegi et al. MOLECULAR CANCER THERAPEUTICS
- Feedback regulation of EGFR signalling: decision making by early and delayed loops
- (2011) Roi Avraham et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Acquired Resistance of Non-Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
- (2010) U. McDermott et al. CANCER RESEARCH
- Receptor Tyrosine Kinase Coactivation Networks in Cancer
- (2010) A. M. Xu et al. CANCER RESEARCH
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes
- (2010) H.-W. Lo et al. MOLECULAR CANCER RESEARCH
- Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
- (2010) A. S. Azmi et al. MOLECULAR CANCER THERAPEUTICS
- Violations of robustness trade-offs
- (2010) Hiroaki Kitano Molecular Systems Biology
- Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics
- (2009) Dennis YQ Wang et al. BMC Systems Biology
- Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
- (2009) F. Qian et al. CANCER RESEARCH
- Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
- (2009) L. Liu et al. CANCER RESEARCH
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data
- (2009) Regina Samaga et al. PLoS Computational Biology
- Endocytosis and intracellular trafficking of ErbBs
- (2008) Alexander Sorkin et al. EXPERIMENTAL CELL RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
- (2008) M A Stutz et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now